ArticleMolecular genetics and metabolism2026

Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis.

Pamela Kell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.